stars 1 stars 2 stars 3

We are now Fortrea. To keep updated on the latest news from Fortrea, please visit our LinkedIn page at https://www.linkedin.com/company/fortrea Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.

Website http://www.fortrea.com/
Revenue $5.9 million
Employees 266 (124 on RocketReach)
Founded 1982
Phone +44 1753 512000
Industry Hospitals and Health Care, Clinical Trials, Biopharma, Clinical Analytics, Medical Device and Diagnostics, Source (FSP/Resourcing), Oncology, Ophthalmology, Respiratory, Anti-infectives/Vaccines, Dermatology, Data Management, Eclinical, Biostatistics, SAS Programming, Clinical Monitoring
Web Rank 6 Million
Keywords Clinical Development, Clinical Operations, Patient Access Solutions, Regulatory Affairs, Clinical Research, Medical Affairs, Pharmaceutical Services, Pharmacovigilance, Drug Development, Drug Safety, Clinical Trials, Healthcare Consulting, Healthcare Solutions, Clinical Monitoring, Biopharmaceutical Services, Data Management, Medical Research, Global Healthcare, Life Sciences
Competitors ICON plc, Research Pharmaceutical Services, IQVIA, PPD, Charles River Laboratories, Synchrony Financial, Medpace, Covance, Worldwide Clinical Trials, KCR CRO LTD +37 more (view full list)

Theorem (now Chiltern) Questions

The Theorem (now Chiltern) annual revenue was $5.9 million in 2026.

Laura Sadowski is the Project Director of Theorem (now Chiltern).

124 people are employed at Theorem (now Chiltern).

Top Theorem (now Chiltern) Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users